Skip to main content
logo
Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
3.450
+0.020 (0.58%)
At close: Jun 12, 2026, 4:00 PM EDT
3.450
0.00 (0.01%)
After-hours: Jun 12, 2026, 7:09 PM EDT

Niagen Bioscience Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
18.6417.388.55-4.94-16.54-27.13
Depreciation & Amortization
0.880.790.811.031.061.12
Stock-Based Compensation
6.716.073.664.755.746.2
Other Adjustments
1.03-2.43-4.051.710.970.67
Change in Receivables
-6.21-0.76-1.282.26-3.32-2.58
Changes in Inventories
-13.22-11.645.330.15-1.08-1.92
Changes in Accounts Payable
2.652.27-1.070.55-0.740.98
Changes in Accrued Expenses
0.511.841.212.160.860.35
Changes in Unearned Revenue
-0.010.1-0.73-0.64-0.39-0.1
Changes in Other Operating Activities
0.14-0.11-0.330.09-1.64-1.75
Operating Cash Flow
4.4313.512.117.12-15.1-24.16
Operating Cash Flow Growth
-77.52%11.52%70.14%---
Capital Expenditures
-0.32-0.29-0.16-0.15-0.33-0.41
Sale of Property, Plant & Equipment
--0.020.01--
Investing Cash Flow
4.99-0.29-0.14-0.14-0.33-0.41
Issuance of Common Stock
4.247.255.43-7.7536.24
Repurchase of Common Stock
-2.35-0.25----
Net Common Stock Issued (Repurchased)
1.8975.43-7.7536.24
Other Financing Activities
-0.07-0.08-0.06-0.09-0.09-0.14
Financing Cash Flow
1.526.925.37-0.097.6536.09
Net Cash Flow
10.9320.1317.346.88-7.7811.52
Free Cash Flow
4.1113.2111.956.97-15.43-24.57
Free Cash Flow Growth
-68.92%10.60%71.42%---
FCF Margin
3.15%10.21%11.99%8.34%-21.42%-36.43%
Free Cash Flow Per Share
0.050.150.150.09-0.22-0.37
Levered Free Cash Flow
9.2710.3413.61-1.75-18.82-28.85
Unlevered Free Cash Flow
-0.864.6512.55-2.41-20.91-28.8
SEC Filings: 10-K · 10-Q